331 related articles for article (PubMed ID: 28692257)
1. Targeting Osteocytes to Attenuate Early Breast Cancer Bone Metastasis by Theranostic Upconversion Nanoparticles with Responsive Plumbagin Release.
Qiao H; Cui Z; Yang S; Ji D; Wang Y; Yang Y; Han X; Fan Q; Qin A; Wang T; He XP; Bu W; Tang T
ACS Nano; 2017 Jul; 11(7):7259-7273. PubMed ID: 28692257
[TBL] [Abstract][Full Text] [Related]
2. Structural simulation of adenosine phosphate via plumbagin and zoledronic acid competitively targets JNK/Erk to synergistically attenuate osteoclastogenesis in a breast cancer model.
Qiao H; Wang TY; Yu ZF; Han XG; Liu XQ; Wang YG; Fan QM; Qin A; Tang TT
Cell Death Dis; 2016 Feb; 7(2):e2094. PubMed ID: 26866274
[TBL] [Abstract][Full Text] [Related]
3. Plumbagin inhibits breast tumor bone metastasis and osteolysis by modulating the tumor-bone microenvironment.
Li Z; Xiao J; Wu X; Li W; Yang Z; Xie J; Xu L; Cai X; Lin Z; Guo W; Luo J; Liu M
Curr Mol Med; 2012 Sep; 12(8):967-81. PubMed ID: 22574935
[TBL] [Abstract][Full Text] [Related]
4. Synergistic suppression of human breast cancer cells by combination of plumbagin and zoledronic acid In vitro.
Qiao H; Wang TY; Yan W; Qin A; Fan QM; Han XG; Wang YG; Tang TT
Acta Pharmacol Sin; 2015 Sep; 36(9):1085-98. PubMed ID: 26235741
[TBL] [Abstract][Full Text] [Related]
5. Bone-Targeted Nanoplatform Combining Zoledronate and Photothermal Therapy To Treat Breast Cancer Bone Metastasis.
Sun W; Ge K; Jin Y; Han Y; Zhang H; Zhou G; Yang X; Liu D; Liu H; Liang XJ; Zhang J
ACS Nano; 2019 Jul; 13(7):7556-7567. PubMed ID: 31259530
[TBL] [Abstract][Full Text] [Related]
6. Development of redox-responsive theranostic nanoparticles for near-infrared fluorescence imaging-guided photodynamic/chemotherapy of tumor.
Yang X; Shi X; Ji J; Zhai G
Drug Deliv; 2018 Nov; 25(1):780-796. PubMed ID: 29542333
[TBL] [Abstract][Full Text] [Related]
7. Plumbagin attenuates cancer cell growth and osteoclast formation in the bone microenvironment of mice.
Yan W; Wang TY; Fan QM; Du L; Xu JK; Zhai ZJ; Li HW; Tang TT
Acta Pharmacol Sin; 2014 Jan; 35(1):124-34. PubMed ID: 24384612
[TBL] [Abstract][Full Text] [Related]
8. Theranostic pH-sensitive nanoparticles for highly efficient targeted delivery of doxorubicin for breast tumor treatment.
Pan C; Liu Y; Zhou M; Wang W; Shi M; Xing M; Liao W
Int J Nanomedicine; 2018; 13():1119-1137. PubMed ID: 29520140
[TBL] [Abstract][Full Text] [Related]
9. Metal-Organic Framework Nanoparticles for Ameliorating Breast Cancer-Associated Osteolysis.
Pang Y; Fu Y; Li C; Wu Z; Cao W; Hu X; Sun X; He W; Cao X; Ling D; Li Q; Fan C; Yang C; Kong X; Qin A
Nano Lett; 2020 Feb; 20(2):829-840. PubMed ID: 31916446
[TBL] [Abstract][Full Text] [Related]
10. Biomimetic Persistent Luminescent Nanoplatform for Autofluorescence-Free Metastasis Tracking and Chemophotodynamic Therapy.
Li YJ; Yang CX; Yan XP
Anal Chem; 2018 Mar; 90(6):4188-4195. PubMed ID: 29504391
[TBL] [Abstract][Full Text] [Related]
11. Using Peptide Aptamer Targeted Polymers as a Model Nanomedicine for Investigating Drug Distribution in Cancer Nanotheranostics.
Zhao Y; Houston ZH; Simpson JD; Chen L; Fletcher NL; Fuchs AV; Blakey I; Thurecht KJ
Mol Pharm; 2017 Oct; 14(10):3539-3549. PubMed ID: 28880092
[TBL] [Abstract][Full Text] [Related]
12. Chemotherapeutic drug-photothermal agent co-self-assembling nanoparticles for near-infrared fluorescence and photoacoustic dual-modal imaging-guided chemo-photothermal synergistic therapy.
Li Y; Liu G; Ma J; Lin J; Lin H; Su G; Chen D; Ye S; Chen X; Zhu X; Hou Z
J Control Release; 2017 Jul; 258():95-107. PubMed ID: 28501673
[TBL] [Abstract][Full Text] [Related]
13. Correction to Targeting Osteocytes to Attenuate Early Breast Cancer Bone Metastasis by Theranostic Upconversion Nanoparticles with Responsive Plumbagin Release.
Qiao H; Cui Z; Yang S; Ji D; Wang Y; Yang Y; Han X; Fan Q; Qin A; Wang T; He XP; Bu W; Tang T
ACS Nano; 2019 Apr; 13(4):4857. PubMed ID: 30938978
[No Abstract] [Full Text] [Related]
14. Osteocytic connexin hemichannels suppress breast cancer growth and bone metastasis.
Zhou JZ; Riquelme MA; Gu S; Kar R; Gao X; Sun L; Jiang JX
Oncogene; 2016 Oct; 35(43):5597-5607. PubMed ID: 27041582
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the combined use of metronomic zoledronic acid and Coriolus versicolor in intratibial breast cancer mouse model.
Ko CH; Yue GG; Gao S; Luo KW; Siu WS; Shum WT; Shiu HT; Lee JK; Li G; Leung PC; Evdokiou A; Lau CB
J Ethnopharmacol; 2017 May; 204():77-85. PubMed ID: 28412218
[TBL] [Abstract][Full Text] [Related]
16. ZnO-functionalized mesoporous inner-empty nanotheranostic platform: upconversion imaging guided chemotherapy with pH-triggered drug delivery.
Wang L; Cai Y; An Z; Gu W; Chen P; Cai Q
Nanotechnology; 2018 Dec; 29(50):505101. PubMed ID: 30207290
[TBL] [Abstract][Full Text] [Related]
17. From The Mine to Cancer Therapy: Natural and Biodegradable Theranostic Silicon Nanocarriers from Diatoms for Sustained Delivery of Chemotherapeutics.
Maher S; Kumeria T; Wang Y; Kaur G; Fathalla D; Fetih G; Santos A; Habib F; Evdokiou A; Losic D
Adv Healthc Mater; 2016 Oct; 5(20):2667-2678. PubMed ID: 27594524
[TBL] [Abstract][Full Text] [Related]
18. Dual-Targeting Biomimetic Semiconducting Polymer Nanocomposites for Amplified Theranostics of Bone Metastasis.
Zhang Y; Wang Y; Zhu A; Yu N; Xia J; Li J
Angew Chem Int Ed Engl; 2024 Jan; 63(2):e202310252. PubMed ID: 38010197
[TBL] [Abstract][Full Text] [Related]
19. Photoacoustic-based nanomedicine for cancer diagnosis and therapy.
Sim C; Kim H; Moon H; Lee H; Chang JH; Kim H
J Control Release; 2015 Apr; 203():118-25. PubMed ID: 25701310
[TBL] [Abstract][Full Text] [Related]
20. Nanosystem composed with MSNs, gadolinium, liposome and cytotoxic peptides for tumor theranostics.
Jin Y; Zhang N; Li C; Pu K; Ding C; Zhu Y
Colloids Surf B Biointerfaces; 2017 Mar; 151():240-248. PubMed ID: 28024200
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
